These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8177722

  • 21. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1568-75. PubMed ID: 15990246
    [Abstract] [Full Text] [Related]

  • 22. Late effects in children after bone marrow transplantation: a review.
    Locatelli F, Giorgiani G, Pession A, Bozzola M.
    Haematologica; 1993 Dec 01; 78(5):319-28. PubMed ID: 8314162
    [Abstract] [Full Text] [Related]

  • 23. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E, Ołdakowska-Jedynak U, Brydak-Godowska J, Paczek L, Kecik D.
    Transplant Proc; 2006 Dec 01; 38(1):292-4. PubMed ID: 16504728
    [Abstract] [Full Text] [Related]

  • 24. Ocular complications of bone marrow transplantation.
    Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ.
    Br J Ophthalmol; 1991 Oct 01; 75(10):611-4. PubMed ID: 1954211
    [Abstract] [Full Text] [Related]

  • 25. [Cataract in children after autologous bone marrow transplantation. A common, but curable complication].
    Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G.
    Lakartidningen; 2002 Mar 27; 99(13):1444-7. PubMed ID: 11989353
    [Abstract] [Full Text] [Related]

  • 26. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT, Törnquist AL, Winiarski J.
    Acta Ophthalmol; 2008 May 27; 86(3):253-8. PubMed ID: 18093259
    [Abstract] [Full Text] [Related]

  • 27. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR.
    Biol Blood Marrow Transplant; 1997 Apr 27; 3(1):25-33. PubMed ID: 9209738
    [Abstract] [Full Text] [Related]

  • 28. Ocular manifestations of graft versus host disease following bone marrow transplantation.
    Claes K, Kestelyn P.
    Bull Soc Belge Ophtalmol; 2000 Apr 27; (277):21-6. PubMed ID: 11126670
    [Abstract] [Full Text] [Related]

  • 29. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R, Sancho G, Bieri S, Carrió I, Helg C, Brunet S, Martin PY, Sureda A, Gomez De Segura G, Chapuis B, Estorch M, Ozsahin M, Keller A.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):809-16. PubMed ID: 14967438
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 01; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 31. Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.
    Hamon MD, Gale RF, Macdonald ID, Smith OP, Collis CH, Skeggs DB, Gandhi L, Prentice HG.
    Bone Marrow Transplant; 1993 Sep 01; 12(3):233-6. PubMed ID: 8241982
    [Abstract] [Full Text] [Related]

  • 32. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
    Anderson JE, Appelbaum FR, Schoch G, Barnett T, Chauncey TR, Flowers ME, Storb R.
    Biol Blood Marrow Transplant; 2001 Sep 01; 7(3):163-70. PubMed ID: 11302550
    [Abstract] [Full Text] [Related]

  • 33. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP, Doria R, Khan K, Zelterman D, Ahmad YH, Smith BR, Holmes W, Becker P, Roberts KB, Rappeport JM.
    Bone Marrow Transplant; 1999 Jun 01; 23(11):1095-100. PubMed ID: 10382947
    [Abstract] [Full Text] [Related]

  • 34. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P.
    Bone Marrow Transplant; 1999 Nov 01; 24(10):1131-6. PubMed ID: 10578163
    [Abstract] [Full Text] [Related]

  • 35. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA, Bowman LC, Woodard JP, Cunningham JM, Benaim E, Horwitz EM, Heslop HE, Krance RA, Leung W, Shearer PD, Handgretinger R.
    Bone Marrow Transplant; 2003 Jun 01; 31(11):981-6. PubMed ID: 12774048
    [Abstract] [Full Text] [Related]

  • 36. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.
    Biol Blood Marrow Transplant; 2004 May 01; 10(5):310-9. PubMed ID: 15111930
    [Abstract] [Full Text] [Related]

  • 37. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 01; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 38. High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation.
    Conter V, D'Angelo P, Rizzari C, Jankovic M, Dampier C, Masera G, Johnson FL.
    Bone Marrow Transplant; 1996 Feb 01; 17(2):287-9. PubMed ID: 8640182
    [Abstract] [Full Text] [Related]

  • 39. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 01; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 40. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
    Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera GB, Bacigalupo A.
    Haematologica; 2003 Oct 01; 88(10):1163-8. PubMed ID: 14555313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.